KRAS and lung adenocarcinoma: For example, in KRAS-mutated lung adenocarcinoma cells, the secretion of proinflammatory cytokines, including interleukin-6, activates JAK1 and JAK2 through glycoprotein 130 in an autocrine loop, thus, contributing to malignant progression.